$3.5MSeries A, 12 March 2026
First close of a Series A funding the pivotal US Phase 3 HIVEC HEAT trial in BCG-unresponsive bladder cancer.
- Amount
- $3.5M
- Stage
- Series A
- Announced
- 12 March 2026
- Lead
- T&J Meyer Family Foundation
- Other investors
- Varia Ventures, NW Angel Fund
- Use of funds
- First close of a Series A funding the pivotal US Phase 3 HIVEC HEAT trial in BCG-unresponsive bladder cancer.
- Checked
- Announced by the company
- Sources
- Combat Medical raises £2.6M Series A first close businesswire.com
Combat Medical raises £2.6M Series A first close pulse2.com